Hydrofarm to retire $109 million term loan with equity, raises $8.3 million gross in offering
Hydrofarm priced a registered direct offering and concurrent private placement with expected gross proceeds of about $8.3 million, and agreed to satisfy its $109 million senior secured term loan in full by issuing 27.5 million shares of Series 1 Non-Voting Convertible Preferred Stock and warrants for 27.5 million common shares. The conversion and warrant exercise require stockholder approval, and the filing lists dilution to existing stockholders as a risk.
Key points
- Offering priced at $0.905 per share; expected gross proceeds of about $8.3 million before placement agent fee and expenses, with closing expected on or about October 27, 2026
- Term loan of $109 million to be satisfied in full through 27.5 million Series 1 Non-Voting Convertible Preferred Stock shares and Lender Warrants for 27.5 million common shares at $0.78 exercise price
- Concurrent private placement includes 9,210,975 Common Warrants exercisable at $0.78 and expiring five and a half years from issuance
- Conversion and warrant exercise are subject to shareholder approval; the filing also cites risk of failing to regain Nasdaq continued listing compliance
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.